About Eshwar Pharmaceuticals Private Limited
Data last updated:
Eshwar Pharmaceuticals Private Limited was a private limited company based in Hyderabad, Telangana, India. The company has been converted to a Limited Liability Partnership (LLP) and no longer exists as a company. For the latest details, refer to the successor LLP. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 May 2008.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2008PTC059164. The company has 3 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹2 Cr and a paid-up capital of ₹1.57 Cr.
Its last annual general meeting (AGM) was held on 28 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 7 – 1 – 390 Flat No.504 Sri Sai Residency Balkampet Main Road, Hyderabad, Telangana, India – 500038.
As per the financials filed for FY 2018, the company reported a revenue of ₹3.36 Cr, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹2.65 Cr (net margin -78.8%) and EBITDA of -₹1.84 Cr (EBITDA margin -54.7%). Revenue has declined at a compounded annual rate (CAGR) of 17% over three years.
The company is associated with 1 brand: Eshwar Pharmaceuticals. As per MCA filings, the company has satisfied charges of ₹2.85 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
The last known website on record is eshwarpharma.com.
Company details
CIN history
Eshwar Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2008PTC059164. The current CIN is U24232TG2008PTC059164, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2008PTC059164 | Current |
| U24232AP2008PTC059164 | Previous |
Contact details
Eshwar Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its website is eshwarpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Registered Address7 – 1 – 390 Flat No.504 Sri Sai Residency Balkampet Main Road, Hyderabad, Telangana, India – 500038
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Eshwar Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Eshwar Pharmaceuticals operates one associated brand: Eshwar Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures active pharmaceutical ingredients and intermediates for the healthcare industry. | eshwarpharma.com |
Business activity
The main business activity of Eshwar Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Eshwar Pharmaceuticals Private Limited, buy the company report.
Financials of Eshwar Pharmaceuticals Private Limited
FY 2018 filings availableEshwar Pharmaceuticals Private Limited reported revenue of ₹3.36 Cr (down 35% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over three years, including a 35% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ₹3.36 Cr | |||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹1.84 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2.65 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -54.7% | |||
| Net Profit Margin | -78.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Eshwar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Eshwar Pharmaceuticals Private Limited
Eshwar Pharmaceuticals has 6 former directors on record and no current directors listed.
Auditor
Eshwar Pharmaceuticals Private Limited is audited by ADUSUMILLI & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ADUSUMILLI & ASSOCIATES | FY 2018 | 006983S |
Shareholding
The shareholding of Eshwar Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Eshwar Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Aug 2014 | 10511630 | Andhra Bank | ₹2.85 Cr | Satisfied |
To see the full charge records of Eshwar Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
Eshwar Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by M/S Bharat Jyoti Impex | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons Private cases SS) | Filed against the company by M/S. Bharat Jyoti Impex | Disposed |
To see the full case history of Eshwar Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eshwar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Eshwar Pharmaceuticals has 3 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Eshwar Pharmaceuticals Private Limited, buy the company report.
Recent activity
Eshwar Pharmaceuticals Private Limited has 6 board changes on record since 2009: 0 appointments and 6 cessations. The latest: Krishna Chaitanya Potluri ceased to be Director on 22 Apr 2019.
Frequently asked questions
Eshwar Pharmaceuticals has been "Converted to LLP" - the business changed its legal structure from a company to a Limited Liability Partnership. The original company no longer exists in its previous form. For the latest information, refer to the successor LLP entity registered with MCA.
Eshwar Pharmaceuticals was a private limited company based in Hyderabad, Telangana, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 14 May 2008 and is registered under CIN U24232TG2008PTC059164. For the latest details, refer to the successor LLP entity.
The CIN (Corporate Identification Number) of Eshwar Pharmaceuticals is U24232TG2008PTC059164. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eshwar Pharmaceuticals was incorporated on 14 May 2008. It is registered with the Registrar of Companies, Hyderabad.
Eshwar Pharmaceuticals can be reached through the website eshwarpharma.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Eshwar Pharmaceuticals is at 7 – 1 – 390 Flat No.504 Sri Sai Residency Balkampet Main Road, Hyderabad, Telangana, India – 500038.
The latest financial statements of Eshwar Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 28 September 2018. Year-wise statements from 2015 are in the company report.
No. Eshwar Pharmaceuticals has 3 GST registrations on record and all of them are cancelled or inactive.
Eshwar Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment.
Eshwar Pharmaceuticals has 2 court cases on record: 2 filed against it.